All Search Results
News Releases
May 10, 2026, 20:00 ET Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer
that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted
More news about: Innovent Biologics
May 08, 2026, 13:48 ET Basata Raises $21M Series A to Rebuild the $1T Operational Layer of American Healthcare
100,000 in the past month, and works with providers some of the largest specialty groups in the country across cardiology, urology, gastroenterology, ophthalmology, and growing.Practices using Basata process 100% of incoming referrals the same day, unlock 50% more administrative labor capacity, and reduce
More news about: Basata
May 07, 2026, 10:08 ET Light Field Technology Market to Reach US$ 440.3 Million by 2032 Expands Amid Rising Demand for Immersive Imaging and AI-Driven Visualization - Persistence Market Research
significant advantages over traditional imaging methods.The healthcare sector is also embracing AI-enhanced light field imaging for radiology, ophthalmology, and surgical planning. According to the Medscape & HIMSS AI Adoption Report 2024, 86% of health systems already use AI technologies, with 60%
More news about: Persistence Market Research Pvt. Ltd.
May 07, 2026, 08:00 ET Artera Announces AI Services Model for Specialty Care, FQHCs and More
diverse clinical areas, including: Behavioral Health, Cardiology, Dermatology, Family Medicine & Primary Care, Gastroenterology, Oncology, Ophthalmology & Optometry, Orthopedics, Otolaryngology (ENT), Pediatrics, Urology, Women's Health and others.Federally Qualified
More news about: Artera
May 07, 2026, 07:05 ET REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting
activity compared to AAV8Poster: 1031Presenter: Brendan Lilley, Ph.D., Director of Ophthalmology Research, REGENXBIOLocation: MCEC Exhibit and Poster Hall (Halls B2-C, Exhibit level)Date/Time: Tuesday,
More news about: REGENXBIO Inc.
